NCT06939972已完成不适用
A Single Group Study to Evaluate the Effects of a Topical Product on Cramps Associated With the Menstrual Cycle
Rael2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年10月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- Reduction in Menstrual Cramps and Pain
研究概览
简要总结
This study evaluates the effectiveness of a topical product in reducing discomfort associated with menstrual cramps and back pain. Participants will apply the product during two menstrual cycles and complete study-specific questionnaires to assess the impact on symptoms and user perceptions.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 35 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Female, aged 18-
- •Has had a regular menstrual cycle for the past six months and is to predict their menstrual cycle and the timing of their menstruation.
- •Mild to moderate self-reported discomfort during menstruation related to pelvic cramps and back pain.
- •Generally healthy and not living with any uncontrolled chronic disease.
- •Has a menstrual cycle between 21 and 35 days in length.
- •Willing to maintain current diet, sleep, and activity level for the duration of the study.
- •Resides in the United States.
排除标准
- •Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
- •Current use of any blood thinning medication.
- •Anyone with known severe allergic reactions.
- •Anyone with any allergies requiring the use of an Epi-Pen.
- •Anyone with any allergies or sensitivities to any of the study product ingredients.
- •Anyone who is pregnant, breastfeeding, or trying to conceive currently or at any point until the end of the study period.
- •Anyone unwilling to follow the study protocol.
- •Anyone taking prescription medications for acute or chronic pain.
- •Anyone with a diagnosis of a condition relating to the menstrual cycle or reproductive system-e.g., polycystic ovary syndrome (PCOS), premenstrual dysphoric disorder (PMDD), endometriosis, etc.
- •Anyone diagnosed with other conditions that may cause lower back, abdominal, or pelvic discomfort- e.g., fibromyalgia, Crohn's, IBS, UC, chronic constipation, frequent UTIs, bacterial vaginosis (BV), or history or kidney stones.
- •Anyone who has changed their birth control in the past three months.
- •Anyone who has had any surgeries or invasive treatments in the past six months or has any planned up until the end of the study period.
- •Anyone with any major illness in the past three months.
- •Anyone currently experiencing symptoms associated with perimenopause.
- •Anyone taking part in any other clinical trials or studies during this study's duration.
- •Anyone with a history of substance abuse.
- •Anyone who is currently a smoker or has been in the past three months.
结局指标
主要结局
Reduction in Menstrual Cramps and Pain
时间窗: Baseline, Day 5 of Cycle 1 (cycle 1 is 4 weeks), and Day 5 of Cycle 2 (cycle 2 is 4 weeks)
Change in participant-reported menstrual cramps and associated pain severity, as assessed by a study-specific questionnaire.
次要结局
- Participant Perception of Product Effectiveness(Baseline, Day 5 of Cycle 1 (cycle 1 is 4 weeks), and Day 5 of Cycle 2 (cycle 2 is 4 weeks))
研究者
研究点 (2)
Loading locations...
相似试验
Unknown
不适用
The Effectiveness of Single Tufted Brush in the Management of Peri-implant MucositisDental ImplantNCT03872687National University Health System, Singapore110
Unknown
不适用
Ametop Compared to Ametop With Pain Ease SprayAnalgesiaTopical AnestheticNCT03749915University of British Columbia240
Unknown
4 期
Clinical Study to Evaluate the Efficacy of Topical Medications Containing Benzoyl Peroxide and Sulfur in the Regression in the Short Time (24 Hours) of Moderate Acne Vulgaris Grade II (Pimples)Treatment of Acne Vulgaris Grade II in a Short Period of Time.NCT01260571Zurita Laboratorio Farmaceutico Ltda.62
已完成
1 期
A Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of LEO 158968Joint PainGout FlaresJoint InflammationNCT06444867LEO Pharma6
已完成
1 期
A Clinical Study to Investigate the Effect on Pain Relief of a Single Dose of JNJ-39439335 in Patients With Chronic Osteoarthritis Pain of the KneeOsteoarthritis, KneeNCT00933582Johnson & Johnson Pharmaceutical Research & Development, L.L.C.33